Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Revenue Quarterly
0
1.5M
3M
4.5M
Q3 '21: 4.3M
Q4 '21: 2.6M
Q1 '22: 3M
Q2 '22: 3.8M
Q3 '22: 2.3M
Q4 '22: 2M
Q1 '23: 2.2M
Q2 '23: 2M
Q3 '23: 23K
Q4 '23: 19K
Q1 '24: 12K
Q2 '24: 10K
Q3 '24: 33K
Q4 '24: 53K
Q1 '25: 43K
Q2 '25: 299K
Q3 '25: 388K
Q4 '25: 412K
Q1 '26: 485K
Q2 '26: 514K
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Gross Profit Quarterly
0
350K
700K
1.1M
Q2 '21: 955.9K
Q3 '21: 978.9K
Q4 '21: 661.2K
Q1 '22: 696.5K
Q2 '22: 903.8K
Q3 '22: 738.6K
Q4 '22: 523.9K
Q1 '23: 656.8K
Q2 '23: 705K
Q3 '23: 649.8K
Q4 '23: 602.7K
Q1 '24: 699.3K
Q2 '24: 10K
Q3 '24: 33K
Q1 '25: 43K
Q2 '25: 274K
Q3 '25: 146K
Q4 '25: 182K
Q1 '26: 221K
Q2 '26: 253K
Q3 '21
Q2 '22
Q1 '23
Q4 '23
Q3 '24
Q3 '25
Q2 '26
Operating Income Quarterly
-4.5M
-3M
-1.5M
0
1.5M
3M
4.5M
Q3 '21: -84.3K
Q4 '21: -2.9M
Q1 '22: -1.7M
Q2 '22: -1.6M
Q3 '22: -1.1M
Q4 '22: -1M
Q1 '23: -954.7K
Q2 '23: 493.1K
Q3 '23: -647K
Q4 '23: -1.6M
Q1 '24: -1.1M
Q2 '24: -1.3M
Q3 '24: -4.3M
Q4 '24: -3.4M
Q1 '25: -2.1M
Q2 '25: -1.6M
Q3 '25: -2.7M
Q4 '25: -2.5M
Q1 '26: -2M
Q2 '26: -2M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-15M
-10M
-5M
0
5M
10M
15M
Q3 '21: -95.5K
Q4 '21: -1.3M
Q1 '22: -2.1M
Q2 '22: -1.5M
Q3 '22: -4.7M
Q4 '22: -9.4M
Q1 '23: -1.3M
Q2 '23: 234.8K
Q3 '23: -650K
Q4 '23: -1.1M
Q1 '24: -1.1M
Q2 '24: -1.3M
Q3 '24: -4.3M
Q4 '24: -3.8M
Q1 '25: -12.9M
Q2 '25: -1.8M
Q3 '25: -2.6M
Q4 '25: -2.5M
Q1 '26: -2M
Q2 '26: -2M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Cost of Revenue Quarterly
0
1.5M
3M
4.5M
Q1 '21: 2.4M
Q2 '21: 3.8M
Q3 '21: 3.3M
Q4 '21: 1.9M
Q1 '22: 2.6M
Q2 '22: 3.4M
Q3 '22: 1.6M
Q4 '22: 1.4M
Q1 '23: 1.5M
Q2 '23: 1.3M
Q3 '23: 1.3M
Q4 '23: 1.2M
Q1 '24: 1.2M
Q2 '24: 0
Q1 '25: 0
Q2 '25: 25K
Q3 '25: 242K
Q4 '25: 230K
Q1 '26: 264K
Q2 '26: 261K
Q2 '21
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-2.7M
-1.8M
-900K
0
900K
1.8M
2.7M
Q3 '21: -309.7K
Q4 '21: -309.2K
Q1 '22: -1.9M
Q2 '22: -2.4M
Q3 '22: -743.8K
Q4 '22: -913.7K
Q1 '23: -1.8M
Q2 '23: -389.2K
Q3 '23: 491.5K
Q4 '23: -510K
Q1 '24: -1.3M
Q2 '24: -1.1M
Q3 '24: -2.5M
Q4 '24: -1.2M
Q1 '25: -2.5M
Q2 '25: -2.4M
Q3 '25: -1.5M
Q4 '25: -1.8M
Q1 '26: -1.9M
Q2 '26: -1.8M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-2.7M
-1.8M
-900K
0
900K
1.8M
2.7M
Q3 '18: -38.8K
Q4 '18: -89.7K
Q1 '19: -160.8K
Q2 '19: -268.3K
Q3 '19: -442.1K
Q4 '19: -54.4K
Q3 '20: 508.2K
Q4 '20: 378.8K
Q1 '21: 158.2K
Q2 '21: -296.8K
Q3 '21: -343.2K
Q4 '21: -322.9K
Q1 '22: -2M
Q2 '22: -2.4M
Q3 '22: -946.8K
Q4 '22: -1.2M
Q1 '23: -1.8M
Q2 '23: -389.2K
Q3 '23: 491.5K
Q4 '23: -510K
Q4 '18
Q3 '19
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q4 '23
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
7M
14M
21M
Q1 '20: 11.2M
Q2 '20: 11.2M
Q3 '20: 11.8M
Q1 '21: 12.3M
Q2 '21: 12.7M
Q3 '21: 12.6M
Q1 '22: 17.3M
Q2 '22: 17.3M
Q3 '22: 18.4M
Q1 '23: 1.9M
Q2 '23: 648.5K
Q3 '23: 3.7M
Q1 '24: 5.2M
Q2 '24: 671.1K
Q3 '24: 7.1M
Q1 '25: 10M
Q2 '25: 12.7M
Q3 '25: 13.5M
Q1 '26: 16.2M
Q2 '26: 20.6M
Q2 '20
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-7.50
-5.00
-2.50
0.00
2.50
5.00
7.50
Q3 '20: 0.00
Q4 '20: 0.04
Q1 '21: 0.07
Q2 '21: 0.07
Q3 '21: 0.04
Q4 '21: -0.10
Q1 '22: -0.24
Q2 '22: -0.33
Q3 '22: -0.58
Q4 '22: -5.80
Q1 '23: -6.38
Q2 '23: -5.93
Q3 '23: -5.85
Q4 '23: -0.81
Q1 '24: -0.33
Q2 '25: -2.94
Q3 '25: -2.53
Q4 '25: -2.24
Q1 '26: -0.63
Q2 '26: -0.59
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q4 '23
Q3 '25
Q2 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.